Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Outfoxing Foxo1 with miR-182

Induction of the microRNA miR-182 by interleukin 2 in helper T lymphocytes targets the transcription factor Foxo1 and promotes clonal expansion. Targeting this process opens new possibilities for adjuvancy, immunosuppression and anti-inflammatory therapeutics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Regulation of the clonal expansion of helper T cells by miR-182.

References

  1. Baltimore, D. et al. Nat. Immunol. 9, 839–845 (2008).

    Article  CAS  Google Scholar 

  2. Stittrich, A. et al. Nat. Immunol. 11, 1057–1062 (2010).

    Article  CAS  Google Scholar 

  3. Sheedy, F. et al. Nat. Immunol. 11, 141–147 (2010).

    Article  CAS  Google Scholar 

  4. Horak, I., Löhler, J., Ma, A. & Smith, K.A. Immunol. Rev. 148, 35–44 (1995).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luke A J O'Neill.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O'Neill, L. Outfoxing Foxo1 with miR-182. Nat Immunol 11, 983–984 (2010). https://doi.org/10.1038/ni1110-983

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni1110-983

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing